Cellistic Logo
  • CDMO Services
    • Cell Line Development
    • Process Development
    • Analytical Development
    • Master Cell Banking
    • Tech Transfer
    • GMP Manufacturing
    • QC Testing
  • Platforms & Technologies
    • Allo Chassis™
    • STAR-CRISPR™
    • Pulse Cell Line Development Platform
    • Cellistic’s Echo Manufacturing Platform
  • GMP Manufacturing
    • Echo™-NK
    • Echo™-Cardio
    • Echo™-Endothelial
    • Echo™-T
  • Facility
  • Expert Insights
    • Announcements
    • Expert Opinion
    • Interviews
    • Podcasts
    • Posters
    • Webinars
  • About
    • Team
    • Careers
    • Events
Contact
Cellistic Logo
  • CDMO Services
    • Cell Line Development
    • Process Development
    • Analytical Development
    • Master Cell Banking
    • Tech Transfer
    • GMP Manufacturing
    • QC Testing
  • Platforms & Technologies
    • Allo Chassis™
    • STAR-CRISPR™
    • Pulse Cell Line Development Platform
    • Cellistic’s Echo Manufacturing Platform
  • GMP Manufacturing
    • Echo™-NK
    • Echo™-Cardio
    • Echo™-Endothelial
    • Echo™-T
  • Facility
  • Expert Insights
    • Announcements
    • Expert Opinion
    • Interviews
    • Podcasts
    • Posters
    • Webinars
  • About
    • Team
    • Careers
    • Events

Announcements

All Announcements Events Expert Opinion Interviews Podcasts Posters Webinars
Cellistic Announces the Appointment of Jonas Mortensen as New Chief Commercial Officer

October 30, 2023

Cellistic Announces the Appointment of Jonas Mortensen as New Chief ...

Mont-Saint-Guibert, Belgium (October 30, 2023) – Cellistic is pleased to announce the ...

Cellistic reveals groundbreaking iPSC-based platforms to accelerate off-the-shelf allogeneic cell therapy development and manufacturing

October 9, 2023

Cellistic reveals groundbreaking iPSC-based platforms to accelerate ...

Mont-Saint-Guibert, Belgium

Ncardia And Cellistic Recruit Charles Jacques as new Chief Financial Officer

August 15, 2023

Ncardia And Cellistic Recruit Charles Jacques as new Chief Financial ...

Leiden, Netherlands and Mont-Saint-Guibert, Belgium (August 15, 2023) – Ncardia and Cellistic ...

The next milestone in allogeneic cell therapy development: FDA approval for allogeneic type 1 diabetes treatment

June 30, 2023

The next milestone in allogeneic cell therapy development: FDA approval ...

The U.S. Food and Drug Administration (FDA) has recently granted approval to Lantidra, an ...

Revolutionizing Cancer Treatment: FDA recently approved an allogeneic CAR-T Therapy

February 9, 2023

Revolutionizing Cancer Treatment: FDA recently approved an allogeneic ...

Autologous CAR-T cell therapy has revolutionized the way some cancers are treated, offering ...

Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth

January 5, 2023

Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses ...

– Gustavo Mahler hired as the Chief Executive Officer of Ncardia and Cellistic, and will join ...

← 1 2 3 →
Cellistic Logo White
  • Services
  • Technologies
  • Cell Types
  • Facility
  • Resources
  • About
  • Contact
  • Team
  • Careers
x-twitter InBug-White-1

Rue Edouard Belin 2
1435 Mont-Saint-Guibert
Belgium

 

partnering@cellistic.com

  • Privacy Policy
  • Cookie Policy